Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy

Detalles Bibliográficos
Autores principales: Rawal, Shalin, Sharma, Kamal, Shah, Aditya, Bavishi, Shriya, Christian, Cleris, Bhatt, Parjanya, Konat, Ashwati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260166/
https://www.ncbi.nlm.nih.gov/pubmed/35811704
http://dx.doi.org/10.3389/fcvm.2022.916705
Descripción
Sumario:

Ejemplares similares